Truemeds is India's first e-pharmacy for senior citizens, aiming to reduce patient’s medicine cost by up to 80%. They use a proprietary algorithm to help patients make smarter choices with their healthcare needs.

Kunal Wani

Akshat Nayyar

Truemeds

Cordia Pharma LTD UK operates in the healthcare industry, providing business process optimization, technology solutions, strategic sourcing, and digital transformation services. This description is self-described.

Cordia Pharma LTD UK

Burden of medicine bills is a leading cause of financial worry among Indian consumers
● 70% of healthcare spend in India is on Medicines
● 15-20% of family income of chronic patients is spent on medicines
● 63 million people in India plunge into poverty annually due to healthcare costs

Our vision is to make healthcare affordable and accessible to all. We are a technology driven, tele-health platform that aims to reduce healthcare expenses and improve healthcare outcomes by democratising medicine purchase in India.

Truemeds, through its proprietary algorithm and tele-consultation, is able to recommend best value medicines to customers with precise scientific matching and outcomes history leading to 50%+ savings for customers!

We have grown at a phenomenal pace with customer love – 60X growth delivered in last 20 months.

Headquartered in Mumbai, we are excited to build a strong product and operations team, which is passionate to build innovative solutions and willing to go the extra mile to ensure the customer has the best experience.

Metric
Company Name	Truemeds	Cordia Pharma LTD UK
Symbol
MSH ID	IN:TRUEMEDS	COM:CORDIAPHARMA
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Healthcare	Healthcare & Health Services
Country	IN	GB
Stage	Series B
Employee Count	410
Website	truemeds.in	cordiapharma.com
LinkedIn	truemeds-india	cordia-pharma-ltd
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.62M
Web Traffic Growth	0.21
Valuation
Raised Capital	21.85M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

IN:TRUEMEDS

Truemeds

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue